BlackRock Health Sciences Trust II
BMEZ
20 hedge funds and large institutions have $87.3M invested in BlackRock Health Sciences Trust II in 2020 Q1 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
4.65% more ownership
Funds ownership: 0% → 4.65% (+4.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$35.7M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$16.8M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$15.9M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$11M |
| 5 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$5.83M |
Top Sellers
BMEZ Hedge Fund Activity: Q1 2020 in Review
20 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust II (BMEZ) for Q1 2020, worth a combined $87.3M.
Buyers outnumbered sellers: 20 funds opened new BMEZ positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $35.7M.
- 20 institutional investors held BlackRock Health Sciences Trust II (BMEZ) as of Q1 2020, up from 0 in Q4 2019.
- Funds reported $87.3M of BlackRock Health Sciences Trust II stock for Q1 2020.
- 20 funds opened new BlackRock Health Sciences Trust II positions in Q1 2020 and 0 closed out, a net change of +20 holders.
- The largest BlackRock Health Sciences Trust II buyer in Q1 2020 was Morgan Stanley, an estimated $35.7M added.
Based on aggregated 13F filings for Q1 2020.